Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
- Status
- RECRUITING
- Phase
- PHASE2
Perioperative Treatment Outcomes of Early NSCLC
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
- Status
- RECRUITING
- Phase
- NA
Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC
- Status
- RECRUITING
- Phase
- N/A
Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
- Status
- RECRUITING
- Phase
- N/A
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2